Compound Detail
CHEMBL5802092
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Cc1nc(N[C@H](C)c2cccc(C(F)F)c2F)c2cn([C@]3(C(F)(F)F)CCOC3)c(=O)cc2n1
Basic Information
| ChEMBL ID | CHEMBL5802092 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ZCXDDJLWNVDNIJ-WSVYEEACSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
0
Publications
0
Known Names
Molecular Properties
486.4
MW (Da)
5.03
ALogP
6
HBA
1
HBD
69.0
PSA (Ų)
0.51
QED
1
Ro5 Violations
5
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 8.3
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| SOS1-KRAS CHEMBL5465393 | IC50 | 8.3 | 8.3 | 5.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| SOS1-KRAS | IC50 | = | 5.0 | nM | 8.3 | TBDAlphaScreen Binding Assay: Compounds are diluted to a final start concentrati... | - |
Data from ChEMBL 36 via Core Engine